Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004981356 | SCV005567820 | uncertain significance | Inborn genetic diseases | 2024-11-15 | criteria provided, single submitter | clinical testing | The c.1180G>C (p.E394Q) alteration is located in exon 17 (coding exon 15) of the ADGRG2 gene. This alteration results from a G to C substitution at nucleotide position 1180, causing the glutamic acid (E) at amino acid position 394 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |